Preferred Label : Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18;
MeSH definition : A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS),
types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES
of these subtypes.;
MeSH hyponym : Gardasil; human papillomavirus vaccine L1, type 6,11,16,18; HPV L1 Vaccine, Quadrivalent 6,11,16,18;
Wikipedia link : https://en.wikipedia.org/wiki/Gardasil;
Is substance : O;
Origin ID : D000068857;
UMLS CUI : C1831799;
ATC code(s)
- Allowable qualifiers
- CISMeF manual mappings
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS),
types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES
of these subtypes.
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=602
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=603
2017
false
false
false
France
French
technical report
papillomavirus vaccines
vaccinia
Infections
infectious disease, nos
infection control
infected
preventive immunization/medication
viral disease other/nos
vaccines
vaccination
Gardasil
vaccine, nos
papillomavirus infections
vaccinia
Infections
vaccines
vaccination
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00222
2017
false
false
false
France
French
health
Gardasil
canada
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=416
2014
false
France
French
immunization schedule
papillomavirus infections
vaccination
papillomavirus (human types 6,11,16,18)
guidelines for drug use
public health guidelines
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
---
http://www.has-sante.fr/portail/jcms/c_1232860/gardasil
http://www.has-sante.fr/portail/display.jsp?id=c_523363
http://www.has-sante.fr/portail/jcms/c_1525559/gardasil
http://www.has-sante.fr/portail/jcms/c_1525984/fr/gardasil-20032013-avis-ct-12747
2013
false
France
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
precancerous conditions
vagina
vaccination
papillomavirus (human types 6,11,16,18)
oncogene proteins, viral
L1 protein, Human papillomavirus type 11
L1 protein, Human papillomavirus type 16
L1 protein, Human papillomavirus type 18
L1 protein, Human papillomavirus type 6
vaccines, synthetic
papillomavirus infections
uterine cervical neoplasms
insurance, health, reimbursement
condylomata acuminata
capsid proteins
treatment outcome
oncogene proteins, viral
capsid proteins
uterine cervical dysplasia
vulva
randomized controlled trials as topic
clinical trials, phase ii as topic
clinical trials, phase iii as topic
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Gardasil
2012
false
United Kingdom
English
French
syndication feed
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
treatment outcome
drug evaluation
papillomavirus infections
vaccination
human papillomavirus 11
human papillomavirus 6
human papillomavirus 16
human papillomavirus 18
uterine cervical neoplasms
uterine cervical neoplasms
papillomavirus (human types 6,11,16,18)
drug evaluation
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/Silgard
2012
false
United Kingdom
French
English
syndication feed
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
papillomavirus infections
vaccination
uterine cervical neoplasms
treatment outcome
drug evaluation
papillomavirus (human types 6,11,16,18)
drug evaluation
summary of product characteristics
package leaflet
precancerous conditions
child
adolescent
condylomata acuminata
---
http://www.has-sante.fr/portail/jcms/c_1250214/cervarix-vaccin-papillomavirus-humain-types-16-18-gardasil-vaccin-papillomavirus-humain-types-6-11-16-18
http://www.has-sante.fr/portail/jcms/c_1517921/fr/cervarix
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
immunization schedule
vaccination
papillomavirus vaccines
papillomavirus vaccines
uterine cervical neoplasms
papillomavirus infections
human papillomavirus vaccine, L1 type 16, 18
human papillomavirus vaccine, L1 type 16, 18
papillomavirus (human types 16,18)
treatment outcome
clinical trials, phase ii as topic
clinical trials, phase iii as topic
precancerous conditions
insurance, health, reimbursement
condylomata acuminata
---
http://www.hcsp.fr/explore.cgi/hcspa20110121_ppmvjfGardasil.pdf
2011
false
France
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Advertising
papillomavirus infections
uterine cervical neoplasms
papillomavirus (human types 6,11,16,18)
public health guidelines
---
http://www.hcsp.fr/explore.cgi/hcspa20111021_gardasil.pdf
http://www.hcsp.fr/explore.cgi/hcspr20111021_gardasil.pdf
2011
false
France
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
adolescent
young adult
papillomavirus infections
uterine cervical neoplasms
technical report
public health guidelines
---
http://www.hcsp.fr/docspdf/avisrapports/hcspa20081017_pub.pdf
2008
false
France
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
uterine cervical neoplasms
Advertising
public health guidelines
---
https://www.inspq.qc.ca/sites/default/files/publications/795_avis_vaccins_papillomehumain.pdf
2008
false
Canada
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
uterine cervical neoplasms
papillomavirus vaccines
human papillomavirus vaccine, L1 type 16, 18
public health guidelines
---
http://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/13328488/Brochure%20HPV.pdf
2008
true
Belgium
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
papillomavirus infections
papillomavirus vaccines
papillomaviridae
belgium
sexual behavior
papillomavirus infections
papillomavirus infections
human papillomavirus vaccine, L1 type 16, 18
public health guidelines
---
https://www.cadth.ca/sites/default/files/pdf/E0048_%20HPV-Vaccines_cetap_fr.pdf
https://www.cadth.ca/sites/default/files/pdf/E0048_%20HPV-Vaccines_cetap_e.pdf
2007
false
Canada
French
English
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
human papillomavirus vaccine, L1 type 16, 18
human papillomavirus vaccine, L1 type 16, 18
papillomavirus vaccines
uterine cervical neoplasms
vaccination
Cost-Benefit analysis
alphapapillomavirus
canada
papillomavirus infections
Evidence-Based medicine
papillomavirus vaccines
injections, intramuscular
uterine cervical neoplasms
papillomavirus vaccines
economic evaluation
drug evaluation
---
http://www.phac-aspc.gc.ca/naci-ccni/lr-sl_2-fra.php
http://www.phac-aspc.gc.ca//naci-ccni/lr-sl_2-eng.php
2007
false
Canada
English
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
papillomavirus infections
uterine cervical neoplasms
risk factors
papillomavirus vaccines
human papillomavirus vaccine, L1 type 16, 18
vaccination
review literature as topic
treatment outcome
papillomavirus vaccines
papillomavirus (human types 6,11,16,18)
drug information
---
https://www.has-sante.fr/jcms/r_1439986
2007
true
France
French
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
papillomavirus infections
uterine cervical neoplasms
child
adolescent
adult
papillomavirus (human types 6,11,16,18)
guidelines for drug use
---
